Here are nine new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Dextroamphetamine extended-release ...

SEOUL, SOUTH KOREA - Media OutReach Newswire - 9 July 2025 - Health2Sync, Asia's leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly injectable using a user-friendly FlexTouch pen.

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Insulin is essential for managing blood sugar in type 2 diabetes, helping the body use sugar for energy. Different types of insulin, such as rapid-acting and long-acting, affect the body differently ...

A landmark study involving over 2 million patients shows weight loss drugs like Ozempic, Wegovy, and Mounjaro double the risk of pancreatitis and cause increased incidents of nausea, arthritis, and ...

The Senate Committee on Health, Education, Labor and Pensions grilled Novo Nordisk's CEO Lars Fruergaard Jørgensen on the company's high price for its weight loss drugs Ozempic and Wegovy in the ...

As a special education teacher living with Type 1 diabetes in Crawfordsville, I’ve relied on insulin to manage my condition since my diagnosis in 2011. Despite my engagement as an #insulin4all ...

Ten widely prescribed and expensive medications used by millions of Americans on Medicare to treat blood clots, cancer, heart disease and diabetes such as Xarelto, Eliquis and Jardiance will be ...

Millions of Americans on Medicare are treating blood clots, cancer, heart disease and diabetes with 10 expensive and widely prescribed medications including Xarelto, Eliquis and Jardiance. Now, the 10 ...

The Biden administration on Thursday released the newly negotiated prices of 10 widely prescribed medications after months of back-and-forth between Medicare and drug manufacturers. The reduced price ...